Publications by authors named "Burnside E"

Background: Ambient artificial intelligence offers promise for improving documentation efficiency and reducing provider burden through clinical note generation. However, challenges persist in workflow integration, compliance, and widespread adoption. This study leveraged a Learning Health System (LHS) framework to align research and operations using a hybrid effectiveness-implementation protocol, embedded as pragmatic trial operations within the electronic health record (EHR).

View Article and Find Full Text PDF

External advisory committees (EACs) are critical peer-review meetings that drive improvement at Clinical and Translational Science Award Program Hubs. Despite their ubiquity, evaluations of EAC optimization and effective implementation remain scarce. We present a two-tiered approach to optimizing EAC meetings through (1) in-depth, topically focused "pre-review" meetings comprised of external topic experts and at least one standing "full-board" EAC member, followed by (2) a traditional "full-board" EAC meeting.

View Article and Find Full Text PDF

Introduction: We sought to develop clinical guidelines within our multidisciplinary Breast Center to support decision-making for managing high-risk breast lesions. The objective is to describe the process used to develop these guidelines and assess perceived acceptability.

Methods: We recruited clinical stakeholders to identify key "high-risk" topics.

View Article and Find Full Text PDF

Unlabelled: Hospitalized adults with opioid use disorder (OUD) are at high risk for adverse events and rehospitalizations. This pre-post quasi-experimental study evaluated whether an AI-driven OUD screener embedded in the electronic health record (EHR) was non-inferior to usual care in identifying patients for Addiction Medicine consults, aiming to provide a similarly effective but more scalable alternative to human-led ad hoc consultations. The AI screener analyzed EHR notes in real-time with a convolutional neural network to identify patients at risk and recommend consultation.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic variants (PVs) in certain genes like BRCA1 and BRCA2 increase breast cancer risk, but it's unclear how risk varies based on the type and location of these variants.
  • This study analyzed breast cancer risks associated with different PV types and locations using data from 12 US studies and clinical cohorts involving over 64,000 women.
  • Results showed that women with specific exon PTVs had higher breast cancer risks, lower rates of ER-negative breast cancer, and were diagnosed at younger ages compared to those with other variants, with these patterns observed across multiple cohorts.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to enhance breast cancer risk modeling by integrating pathogenic variants (PVs) in specific genes, a polygenic risk score (PRS), and an epidemiologic risk score (ERS) using data from over 23,000 breast cancer cases and controls.
  • - The results showed that postmenopausal women with no PVs but high ERS had a 4.4-fold increase in breast cancer risk, while some CHEK2 PV carriers had a predicted lifetime risk below 20%, indicating potential over-screening in certain groups.
  • - The findings suggest that combining these risk factors can improve risk assessment and possibly lead to more tailored screening and prevention strategies for breast cancer.
View Article and Find Full Text PDF

In evidence-based medicine frameworks, the highest level of evidence is derived from quantitative synthesis of double-masked, high-quality, randomly assigned controlled trials. Meta-analyses of randomly assigned controlled trials have demonstrated that screening mammography reduces breast cancer deaths. In the United States, every major guideline-producing organization has recommended screening mammography in average-risk women; however, there are controversies about age and frequency.

View Article and Find Full Text PDF

Purpose: Cancer detection rate (CDR), an important metric in the mammography screening audit, is designed to ensure adequate sensitivity. Most practices use biopsy results as the reference standard; however, commonly ascertainment of biopsy results is incomplete. We used simulation to determine the relationship between the cancer ascertainment rate of biopsy (AR-biopsy), CDR estimation, and associated error rates in classifying whether practices and radiologists meet the established ACR benchmark of 2.

View Article and Find Full Text PDF

Background: Primary care clinicians screen for breast cancer risk factors and assess the risk level of their patients. Women at high risk for breast cancer (eg, 5-year risk of at least 3% or lifetime risk of ≥20%) are eligible for enhanced screening and/or chemoprophylaxis. However, many clinicians do not identify women at high risk and offer appropriate referrals, screening, or chemoprophylaxis.

View Article and Find Full Text PDF

Despite understanding its impact on organizational effectiveness, practical guidance on how to train translational team (TT) leaders is lacking. Previously, we developed an evolutionary learning model of TT maturation consisting of three goal-directed phases: (1). team assembly (); (2).

View Article and Find Full Text PDF

Purpose: Germline pathogenic variants in CHEK2 confer moderately elevated breast cancer risk (odds ratio, OR ∼ 2.5), qualifying carriers for enhanced breast cancer screening. Besides pathogenic variants, dozens of missense CHEK2 variants of uncertain significance (VUS) have been identified, hampering the clinical utility of germline genetic testing (GGT).

View Article and Find Full Text PDF

Successful translation involves the coupled application of knowledgegenerating research with product development to advance a device, drug, diagnostic, or evidence-based intervention for clinical adoption to improve human health. Critical to the success of the CTSA consortium, translation can be more effectively accomplished by training approaches that focus on improving team-emergent knowledge skills and attitudes (KSAs) linked to performance. We earlier identified 15 specific evidence-informed, team-emergent competencies that facilitate translational team (TT) performance.

View Article and Find Full Text PDF

Background: The clinical narrative in electronic health records (EHRs) carries valuable information for predictive analytics; however, its free-text form is difficult to mine and analyze for clinical decision support (CDS). Large-scale clinical natural language processing (NLP) pipelines have focused on data warehouse applications for retrospective research efforts. There remains a paucity of evidence for implementing NLP pipelines at the bedside for health care delivery.

View Article and Find Full Text PDF

A translational team (TT) is a specific type of interdisciplinary team that seeks to improve human health. Because high-performing TTs are critical to accomplishing CTSA goals, a greater understanding of how to promote TT performance is needed. Previous work by a CTSA Workgroup formulated a taxonomy of 5 interrelated team-emergent competency "domains" for successful translation: 1).

View Article and Find Full Text PDF

Roussel et al. provide new insight into mecencephalic locomotor region (MLR) stimulation to treat spinal cord injury in mice. Previously, it was unclear which part of the MLR to target.

View Article and Find Full Text PDF

Background: Clinical decision aids may support shared decision-making for screening mammography. To inform shared decision-making between patients and their providers, this study examines how patterns of using an EHR-integrated decision aid and accompanying verbal patient-provider communication predict decision-making satisfaction.

Methods: For 51 patient visits during which a mammography decision aid was used, linguistic characteristics of patient-provider verbal communication were extracted from transcribed audio recordings and system logs automatically captured uses of the decision aid.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to enhance shared decision making (SDM) for breast cancer screening in women aged 40-49, addressing challenges with innovative quality improvement and team science methods.
  • An interdisciplinary team worked over six years using a plan-do-study-act approach to develop and implement a SDM tool known as the Breast Cancer Risk Estimator, which was well-received by 87% of patients.
  • Results showed increased usage of the tool from 2,000 to 4,097 sessions over two years, indicating that effective team collaboration and data support were crucial for the success of improving cancer care delivery.
View Article and Find Full Text PDF

Cervical level spinal cord injury (SCI) can severely impact upper limb muscle function, which is typically assessed in the clinic using electromyography (EMG). Here, we established novel preclinical methodology for EMG assessments of muscle function after SCI in awake freely moving animals. Adult female rats were implanted with EMG recording electrodes in bicep muscles and received bilateral cervical (C7) contusion injuries.

View Article and Find Full Text PDF

Overdiagnosis of breast cancer, defined as diagnosing a cancer that would otherwise not cause symptoms or death in a patient's lifetime, costs U.S. health care system over $1.

View Article and Find Full Text PDF
Article Synopsis
  • Guidelines for breast cancer follow-up recommend imaging for distant metastases only when patients show symptoms, but new research suggests better imaging methods could improve survival rates.
  • In a study of 10,076 women with stage II-III breast cancer, it was found that 23.3% of distant recurrences were detected through imaging, while the majority were symptomatic detections.
  • Asymptomatic imaging was linked to a lower risk of death in patients with triple-negative and HER2-positive cancers, indicating a need for updated clinical recommendations and a randomized trial to explore these findings further.
View Article and Find Full Text PDF

This case-based review details screening and management strategies that can maximize the care you provide to women at heightened risk.

View Article and Find Full Text PDF
Article Synopsis
  • Chondroitin sulfate proteoglycans (CSPGs) hinder axonal growth and neuroplasticity following spinal cord injury.
  • CSPGs block the conversion of pro-inflammatory immune cells to a pro-repair state, affecting recovery.
  • Their action involves TLR4 signaling, which promotes prolonged inflammation and tissue damage post-injury.
View Article and Find Full Text PDF
Article Synopsis
  • Gene therapy shows promise for spinal cord regeneration, but controlling gene expression timing is crucial to avoid side effects.
  • The doxycycline-inducible system used for gene expression faces challenges due to its reliance on a bacterial transactivator that can provoke immune responses, limiting its clinical use.
  • A new chimeric transactivator, GARrtTA, demonstrates improved immune evasion and lasts longer in spinal cord applications than the standard rtTA system, leading to healthier cells and reduced cytotoxic T-cell recruitment.
View Article and Find Full Text PDF

Purpose: Data on utilization rate and cancer yield of BI-RADS® category 3 in routine clinical practice in diagnostic mammography are sparse. The aim of this study was to determine utilization rate and cancer yield of BI-RADS 3 in diagnostic mammography in the ACR National Mammography Database (NMD).

Methods: Retrospective analysis of NMD mammograms from January 1, 2009, to June 30, 2018, was performed.

View Article and Find Full Text PDF